Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth.

We cloned the forkhead box C1 (FOXC1) gene, a member of the forkhead/winged-helix transcription factor family, as a transforming growth factor-beta1 (TGF-beta1) responsive gene. We showed that TGF-beta1 upregulated transcription of FOXC1 in several human cancer cell lines. Ectopic expression of FOXC1 cDNA in HeLa cells, which lack both copies of the FOXC1 allele, restores the potential of TGF-beta1 to inhibit cell growth by arresting cells in the G0/G1 phase. In addition, screens of primary endometrial and ovarian cancers revealed homozygous deletion of FOXC1 in 6.7% of them, one nonsense and one missense mutation of FOXC1, and transcriptional silencing in 11.7% of primary cancers. Evidence that a significant fraction of primary cancers exhibited somatic mutations suggests that FOXC1 functions as a tumor suppressor through TGF-beta1 mediated signals.

[1]  J. Graff,et al.  Transforming Growth Factor-β Receptor Type I Gene Is Frequently Mutated in Ovarian Carcinomas , 2001 .

[2]  M. Loda,et al.  Forkhead Transcription Factors Are Critical Effectors of Cell Death and Cell Cycle Arrest Downstream of PTEN , 2000, Molecular and Cellular Biology.

[3]  N. Wake,et al.  Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. , 2000, Cancer research.

[4]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[5]  V. Sheffield,et al.  Expression of the Mf1 gene in developing mouse hearts: Implication in the development of human congenital heart defects , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[6]  M. Ozturk,et al.  Smad2 and Smad4 gene mutations in hepatocellular carcinoma , 1999, Oncogene.

[7]  R. Minami,et al.  Involvement of mutations in the DPC4 promoter in endometrial carcinoma development , 1999, Molecular carcinogenesis.

[8]  L. Gold,et al.  Loss of Growth Regulation by Transforming Growth Factor - β (TGF-β) in Human Cancers: Studies on Endometrial Carcinoma , 1999 .

[9]  T. Gelehrter,et al.  Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.

[10]  J. Morissette,et al.  Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. , 1998, American journal of human genetics.

[11]  B. Hogan,et al.  The Forkhead/Winged Helix Gene Mf1 Is Disrupted in the Pleiotropic Mouse Mutation congenital hydrocephalus , 1998, Cell.

[12]  V. Sheffield,et al.  The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25 , 1998, Nature Genetics.

[13]  K. Miyazono,et al.  HNPCC associated with germline mutation in the TGF-β type II receptor gene , 1998, Nature Genetics.

[14]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[15]  G. Ruvkun,et al.  The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans , 1997, Nature.

[16]  Minoru Watanabe,et al.  Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.

[17]  K. Kinzler,et al.  Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.

[18]  P. Yaswen,et al.  Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells , 1997, Molecular and cellular biology.

[19]  C. Hill.  Signalling to the nucleus by members of the transforming growth factor-β (TGF-β) superfamily , 1996 .

[20]  T. Mitsudomi,et al.  Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. , 1996, Cancer research.

[21]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Knöchel,et al.  Five years on the wings of fork head , 1996, Mechanisms of Development.

[23]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[24]  Xiao-Fan Wang,et al.  Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.

[25]  H. Moses,et al.  Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. , 1995, Cancer research.

[26]  A. Iavarone,et al.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.

[27]  P. Carlsson,et al.  Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. , 1994, The EMBO journal.

[28]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[29]  K. Flanders,et al.  Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites. , 1994, Endocrinology.

[30]  A. Arıcı,et al.  Expression of transforming growth factor-beta 1 messenger ribonucleic acid and the modulation of deoxyribonucleic acid synthesis by transforming growth factor-beta 1 in human endometrial cells. , 1994, American journal of obstetrics and gynecology.

[31]  D. Volpin,et al.  Identification of a TGF-β Responsive Element in the Human Elastin Promoter , 1994 .

[32]  M. Jamrich,et al.  A novel, activin-inducible, blastopore lip-specific gene of Xenopus laevis contains a fork head DNA-binding domain. , 1992, Genes & development.

[33]  K. Flanders,et al.  Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. , 1992, Endocrinology.

[34]  R. de Groot,et al.  Transcriptional activation by TGF beta 1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). , 1990, Biochemical and biophysical research communications.